Answers are grounded in this paper and cite their sources.
Allogeneic stem cell transplantation (alloSCT) of homozygous CCR5 Δ32 stem cells once resulted in the cure of human immunodeficiency virus (HIV) infection. We have recently reported a viral breakthrough in a similar setting. Here, we demonstrate that the rapid rebound after alloSCT was related to a highly replicative CXCR4-tropic HIV variant, which could already be detected before alloSCT.
No takes yet. Share an insight, caveat, or question.
Verheyen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: